| Sep 18 |
Applied Therapeutics: FDA Stance Change For Advisory Panel Bodes Well For Review
|
| Sep 18 |
Why Applied Therapeutics Stock Is Skyrocketing Today
|
| Sep 18 |
Applied Therapeutics Stock Soars As FDA Scraps Panel Meeting For Its Inherited Metabolic Disorder Drug
|
| Sep 18 |
Applied Therapeutics soars as FDA cancels AdCom for lead drug
|
| Sep 18 |
Applied Therapeutics Provides Regulatory Update on Govorestat for the Treatment of Classic Galactosemia
|
| Sep 12 |
Why Champions Oncology Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
|
| Sep 4 |
Applied Therapeutics: Pushing Towards FDA Approval
|
| Sep 4 |
Applied Therapeutics to Participate in Upcoming Investor Conferences
|
| Aug 7 |
Applied Therapeutics GAAP EPS of -$0.13
|
| Aug 7 |
Applied Therapeutics Reports Second Quarter 2024 Financial Results
|
